(Q34979657)

5 August 2017

title

Citalopram in children and adolescents with depression or anxiety (English)

1 reference

5 August 2017

1 reference

3

M Lynn Crismon

1 reference

5 August 2017

2

Graham J Emslie

1 reference

5 August 2017

author name string

Jennifer L Baumgartner

series ordinal

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

Annals of Pharmacotherapy

5 August 2017

published in

1 reference

5 August 2017

volume

36

1 reference

5 August 2017

issue

11

1 reference

5 August 2017

page(s)

1692-1697

1 reference

Epidemiology of childhood depressive disorders: a critical review

5 August 2017

cites work

1 reference

The prevalence of overanxious disorder and separation anxiety disorder: results from the Ontario Child Health Study

21 January 2018

1 reference

Uncommon troubles in young people: prevalence estimates of selected psychiatric disorders in a nonreferred adolescent population

21 January 2018

1 reference

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

21 January 2018

1 reference

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

21 January 2018

1 reference

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression

21 January 2018

1 reference

Citalopram decreases desirability, liking, and consumption of alcohol in alcohol-dependent drinkers

21 January 2018

1 reference

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

21 January 2018

1 reference

A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia

21 January 2018

1 reference

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

21 January 2018

1 reference

Citalopram 20 mg, 40 mg and 60 mg are all effective and well tolerated compared with placebo in obsessive-compulsive disorder

21 January 2018

1 reference

Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorder: a single-blind study.

21 January 2018

1 reference

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

21 January 2018

1 reference

Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania

21 January 2018

1 reference

A retrospective study of citalopram in adolescents with depression

21 January 2018

1 reference

Fluoxetine in children and adolescents with mood disorders: a chart review of efficacy and adverse effects

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1C078

1 reference

5 August 2017

1 reference